STAT+: Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s Olympics in Paris.
Eli Lilly CEO Dave Ricks made $114 million in 2024, according to a new proxy statement to investors, putting him in the rare company of health care executives who have pulled in at least nine figures in a single year.
The drug company also detailed approximately $186,000 in reimbursed expenses that Ricks and two other Lilly officials were paid for the company’s “global executive leadership meeting” that took place in Paris “in conjunction with the 2024 Olympic and Paralympic Games,” the proxy statement said.
